$1.25
0.108.7%
Last update: Nov 9, 12:24 AM
Cellectar Biosciences Inc
CLRBNASDAQ
The average analyst price target for Cellectar Biosciences is $286.67, 22833.6% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $10 to $840. The latest change came on May 15, 2026, when Ladenburg Thalmann assumed coverage of Cellectar Biosciences with a Buy rating and a $10 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
